Despite extensive research in hematological malignancies, any roles of NPM1 in solid tumors, its impact on adult tissue homeostasis and the potential for repurposing emerging AML-targeted NPM1 therapies to benefit more patients remain unclear. Here, NPM1 is linked to hematologic disorder.